1-oxido-2-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)sulfanyl]pyridin-1-ium,hexafluorophosphate

We are 1-oxido-2-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)sulfanyl]pyridin-1-ium,hexafluorophosphate CAS:366821-62-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-oxido-2-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)sulfanyl]pyridin-1-ium,hexafluorophosphate
CAS.NO:366821-62-7
Synonyms:S-(1-Oxo-2-pyridyl)thio-1,3-dimethylpropyleneuroniumhexafluorophosphate;HPTDP
Molecular Formula:C11H16F6N3OPS
Molecular Weight:383.29300
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥97.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent

1-oxido-2-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)sulfanyl]pyridin-1-ium,hexafluorophosphate


Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.4-Fluoro-2-methoxy-5-nitroaniline Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.3-Chloropropyldichloromethylsilane China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.

Related Products
Product Name
N,N’-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine View Details
methyl 3-amino-4,4-dimethoxybut-2-enoate View Details
(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid View Details
3-Bromo-5-(trifluoromethyl)pyridine manufacturer 1,3-Dibromo-2,2-dimethoxypropane manufacturer Diethyl (hydroxymethyl)phosphonate manufacturer 2,8-bis(trifluoromethyl)-1H-quinolin-4-one manufacturer Ethyl 7-chloro-2-oxoheptanoate manufacturer